Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine ...

WHITE PLAINS, N.Y., Sept. 20, 2012 /PRNewswire/ -- Thanks to support funding from The Leukemia & Lymphoma Society (LLS), Onconova Therapeutics, Inc. has been advancing rigosertib, the lead compound ...

Through its Centers of Excellence program, the MDS Foundation helps patients get appointments with leading experts from around the world. For patients with cancer there is no time to waste. The MDS ...

It is estimated that by 2020, there will be a 26% increase in demand for MDS coordinators. Consulting company Pathway Health Services has started a program to help meet the demand for MDS ...

NEW YORK, Oct. 30, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced today that the next stage of development for its CD33 ARC (Antibody Radiation Conjugate) ...